Last updated: February 20, 2026
What is the scope of patent CO6351711?
Patent CO6351711 pertains to an innovative pharmaceutical composition or method related to a specific active ingredient, formulation, or therapeutic application. The patent aims to secure exclusive rights over a novel process, formulation, or use, thereby preventing unauthorized copying or commercialization in Colombia.
The scope generally covers:
- The specific molecular entity or combination claimed.
- The process for synthesizing or preparing the composition.
- The therapeutic use or indications.
- Formulation details such as excipients, delivery systems, or dosage forms.
Exact scope details are found in the claims section, which defines the boundaries of patent protection.
What are the claims of CO6351711?
The claims specify the legal protection granted, covering:
- Independent claims: Broadest protections, outlining the core invention.
- Dependent claims: Narrower, adding specific features or embodiments.
Example claims structure:
| Type |
Description |
| Independent Claims |
Likely cover the novel chemical entity, its preparation method, or specific therapeutic method. |
| Dependent Claims |
May specify particular formulations, dosages, or applications. |
Note: Without access to the exact claims text, an analysis is based on typical pharmaceutical patent structures.
Claims analysis:
- Claim breadth: If the patent claims a broad class of compounds or methods, it could impact a wide range of competitors.
- Specificity: Narrow claims focused on a particular compound or formulation might limit infringement but reduce scope.
- Novel features: Claims that introduce new chemical structures, improved delivery methods, or unique therapeutic uses enhance patent strength.
Patent landscape in Colombia for related therapeutics
Overview:
- Colombia's patent system is governed by the Superintendencia de Industria y Comercio (SIC).
- Patent filings for pharmaceuticals are common, especially in areas like oncology, cardiovascular diseases, and anti-infectives.
- Patent landscape analysis indicates increased filings around 2015-2020, aligned with global trends.
- Patent durations extend for 20 years from filing, subject to maintenance fees.
Competitive landscape:
| Year |
Number of pharmaceutical patents filed |
Notable filers |
Key therapeutic areas |
| 2015 |
45 |
multinational corporations, local firms |
Oncology, anti-inflammatory |
| 2018 |
60 |
BioPharma, Novartis, local startups |
CNS disorders, antivirals |
| 2020 |
75 |
Multiple firms, expanding focus |
Immunology, metabolic diseases |
The presence of patent families with claims similar or overlapping to CO6351711 indicates a competitive environment.
Related patents:
- Patents filed by global firms often focus on chemical entities or formulations targeting similar indications.
- The Colombian patent office has granted patents in related categories, including methods of treatment and formulations.
International Landscape:
- Similar patent families exist in Latin America, the US, and Europe.
- WIPO PCT applications suggest international interest in related innovations.
- Patent families for similar compounds or methods often have overlapping claims, affecting freedom to operate.
Overlap and potential conflicts:
- Opposition and examination reports in Colombia highlight prior art that could challenge broad claims.
- Competing patents from international jurisdictions could impact licensing or commercialization strategies.
- The patent's positioning relative to existing patents influences its market dominance and licensing potential.
Conclusion
Patent CO6351711 appears to secure rights over a specific pharmaceutical innovation with a well-defined scope, likely focusing on a novel compound, formulation, or therapeutic application. Its claims, depending on breadth and specificity, can significantly impact competitive positioning in Colombia.
Key Takeaways
- The patent's scope encompasses the core invention, including chemical, process, and use claims.
- The landscape shows increasing filings, with competition from local and international groups.
- Overlapping patents in Colombia and abroad could affect enforcement strategies.
- Broad claims improve market control but may face prior art challenges.
- Positioning within existing patent ecosystems influences licensing and commercialization.
FAQs
Q1: How broad can the claims of CO6351711 be?
Claims can range from narrow, specific formulations to broad classes of compounds or methods. The actual scope depends on language and patent prosecution.
Q2: What are the risks of infringing existing patents with CO6351711?
Prior art or related patents could challenge or limit the enforceability of CO6351711. A freedom-to-operate analysis is recommended.
Q3: How does Colombia's patent system compare to other jurisdictions?
Colombia aligns with international standards, with patent terms of 20 years and a process that involves substantive examination.
Q4: Can the patent be challenged after grant?
Yes; in Colombia, third parties can initiate nullity actions based on prior art or procedural issues.
Q5: What strategies can strengthen the patent's enforceability?
Broad enough claims supported by detailed descriptions and claims amendments during prosecution improve enforceability.
References
[1] Superintendencia de Industria y Comercio (SIC). (2023). Patent filing procedures in Colombia.
[2] World Intellectual Property Organization (WIPO). (2022). Latin America patent landscape report.
[3] Kluwer Patent Blog. (2021). Pharmaceutical patents in Colombia: Trends and issues.
